Screening compound: InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3

Screening compound: InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3
Screening compound: InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S422-0219

Molecular Formula

C18H20N2O2 (C18 H20 N2 O2)

Compound Name

2-ethoxy-6-(2-methylbenzoyl)-5,6,7,8-tetrahydro-1,6-naphthyridine

IUPAC name

2-ethoxy-6-(2-methylbenzoyl)-5678-tetrahydro-16-naphthyridine

SMILES

CCOc1nc(CCN(C2)C(c3c(C)cccc3)=O)c2cc1

InChI

InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3

InChI Key

BAJGHDRONAPXCH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29005140

InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cardiovascular Library (22201 compounds)

GABA Library (7115 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cardiovascular
  • Eye
  • Cancer
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
  • Ion Channels
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3?
Check Price and Availability of InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H20N2O2/c1-3-22-17-9-8-14-12-20(11-10-16(14)19-17)18(21)15-7-5-4-6-13(15)2/h4-9H,3,10-12H2,1-2H3 available by request